Calex alfred4/20/2023 Later he was employed by the University of Sydney as a Reader in the School of Chemistry for his research work on chemical reaction kinetics. Mark has previously worked at the James Franck Institute at the University of Chicago, and as an Assistant Professor of the University of Rochester NY, USA, where he was awarded the Alfred P Sloan Fellowship for his work. ![]() Mark is a qualified physical chemist with 40 years’ experience. Mark founded Calix in 2005, was re-elected as a Director in 2014 and is a member of Calix’s Technology Committee. Helen is Chair of Calix’s Audit and Risk Management Committtee. Helen has Bachelor degrees in Law (with honours) and Science from the University of Melbourne, a Masters degree in Laws (specialising in International Taxation) from the University of Melbourne and a Masters degree in Commerce from the University of NSW. Helen has provided strategic tax advice to publicly listed and large multinational companies and has extensive experience with capital raisings, licensing deals, demergers, implementing offshore structures, IP and supply chain management. She also specialised in the financial services sector, servicing some of the large banks and funds and has been involved in setting up a number of large international funds, as well as advised on a number of significant M&A transactions. Prior to establishing the BCIF, Helen was a partner of Deloitte and led Deloitte’s life sciences practice in Australia for 5 years, having had many years’ experience in the life sciences and health care sector. She is also the Chair of the Victorian branch of AusBiotech, and a former member of the American Chamber of Commerce in Australia Health Committee. She is currently a Non-Executive Director and Chair of the Audit and Risk Management Committee of Paradigm Biopharmaceuticals Ltd (ASX:PAR). Helen is the founding CEO and Managing Director of Bio Capital Impact Fund (BCIF). Helen Fisher is a passionate leader with a rare combination of financial expertise and deep knowledge and global networks in the Life Sciences sector. Peter is Chair of the Remuneration and Nomination Committee and a member of the Audit and Risk Management Committee. Peter is a non-executive director, former President, Life Member and Fellow of Governance Institute of Australia and is a Fellow of the Australian Institute of Company Directors. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |